WITHDRAWN: Zn-MOF hydrogel: Regulation of ROS-mediated inflammatory microenvironment for treatment of atopic dermatitis
Abstract Atopic dermatitis (AD) is a chronic and recurrent inflammation disease associated with immune dysfunction. The high level of reactive oxygen species (ROS) causes high oxidative stress and further results in the deterioration of AD. Here, a Zn-MOF hydrogel is prepared to regulate ROS-mediated inflammatory microenvironment. The hydrogel with high ROS scavenging performance has a good protective effect on cells. The antibacterial agent Zn-MOF(ZIF-8) loaded into the hydrogel (GelZIF-8) can reduce its toxic and side effects and show a lasting and effective antibacterial activity. In the AD-induced mouse model, Gel@ZIF-8 can significantly enhance the therapeutic effect, such as reduce the thickness of epidermis, the number of mast cells and IgE antibodies. The results indicate that the ROS-scavenging hydrogel could treat the AD by regulating the inflammatory microenvironment, providing a promising treatment for managing AD..
Medienart: |
Preprint |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
ResearchSquare.com - (2024) vom: 15. März Zur Gesamtaufnahme - year:2024 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Qiu, Lirong [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
doi: |
10.21203/rs.3.rs-2623820/v1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
XRA038885581 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | XRA038885581 | ||
003 | DE-627 | ||
005 | 20240316173919.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230308s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.21203/rs.3.rs-2623820/v1 |2 doi | |
035 | |a (DE-627)XRA038885581 | ||
035 | |a (ResearchSquare)10.21203/rs.3.rs-2623820/v1 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Qiu, Lirong |e verfasserin |4 aut | |
245 | 1 | 0 | |a WITHDRAWN: Zn-MOF hydrogel: Regulation of ROS-mediated inflammatory microenvironment for treatment of atopic dermatitis |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Abstract Atopic dermatitis (AD) is a chronic and recurrent inflammation disease associated with immune dysfunction. The high level of reactive oxygen species (ROS) causes high oxidative stress and further results in the deterioration of AD. Here, a Zn-MOF hydrogel is prepared to regulate ROS-mediated inflammatory microenvironment. The hydrogel with high ROS scavenging performance has a good protective effect on cells. The antibacterial agent Zn-MOF(ZIF-8) loaded into the hydrogel (GelZIF-8) can reduce its toxic and side effects and show a lasting and effective antibacterial activity. In the AD-induced mouse model, Gel@ZIF-8 can significantly enhance the therapeutic effect, such as reduce the thickness of epidermis, the number of mast cells and IgE antibodies. The results indicate that the ROS-scavenging hydrogel could treat the AD by regulating the inflammatory microenvironment, providing a promising treatment for managing AD. | ||
650 | 4 | |a Biology |7 (dpeaa)DE-84 | |
650 | 4 | |a 570 |7 (dpeaa)DE-84 | |
700 | 1 | |a Ouyang, Chengcheng |4 aut | |
700 | 1 | |a Zhang, Wei |4 aut | |
700 | 1 | |a Liu, Jia |4 aut | |
700 | 1 | |a Yu, Luting |4 aut | |
700 | 1 | |a Chen, Guoguang |4 aut | |
700 | 1 | |a Ren, Lili |4 aut | |
773 | 0 | 8 | |i Enthalten in |t ResearchSquare.com |g (2024) vom: 15. März |
773 | 1 | 8 | |g year:2024 |g day:15 |g month:03 |
856 | 4 | 0 | |u https://doi.org/10.1186/s12951-023-01924-0 |z lizenzpflichtig |3 Volltext |
856 | 4 | 0 | |u http://dx.doi.org/10.21203/rs.3.rs-2623820/v1 |z kostenfrei |3 Volltext |
912 | |a GBV_XRA | ||
951 | |a AR | ||
952 | |j 2024 |b 15 |c 03 |